CJC-1295 Therapy in Austin
CJC-1295 is a long-acting GHRH analogue that provides a sustained elevation of growth hormone levels. Commonly stacked with Ipamorelin for a synergistic effect.
Key Benefits
How It Works
Binds to GHRH receptors with a drug affinity complex (DAC) that extends half-life to 6–8 days.
Delivery Methods
- Subcutaneous injection
Typical Protocol
Subcutaneous injection, 1–2mg once or twice weekly.
Most effective when combined with a GHRP like Ipamorelin.